• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描/计算机断层扫描成像显示的良性及典型“勿触碰”骨病变表现。

Positron emission tomography/computed tomography imaging appearance of benign and classic "do not touch" osseous lesions.

作者信息

Elangovan Stacey M, Sebro Ronnie

机构信息

Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, United States.

出版信息

World J Radiol. 2019 Jun 28;11(6):81-93. doi: 10.4329/wjr.v11.i6.81.

DOI:10.4329/wjr.v11.i6.81
PMID:31396371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6597458/
Abstract

BACKGROUND

Classic "do not touch" and benign osseous lesions are sometimes detected on -F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) studies. These lesions are often referred for biopsy because the physician interpreting the PET/CT may not be familiar with the spectrum of F-FDG uptake patterns that these lesions display.

AIM

To show that "do not touch" and benign osseous lesions can have increased F-FDG uptake above blood-pool on PET/CT; therefore, the CT appearance of these lesions should dictate management rather than the standardized uptake values (SUV).

METHODS

This retrospective study evaluated 287 independent patients with 287 classic "do not touch" (benign cystic lesions, insufficiency fractures, bone islands, bone infarcts) or benign osseous lesions (hemangiomas, enchondromas, osteochondromas, fibrous dysplasia, Paget's disease, osteomyelitis) who underwent F-FDG positron emission tomography/computed tomography (PET/CT) at a tertiary academic healthcare institution between 01/01/2006 and 12/1/2018. The maximum and mean SUV, and the ratio of the maximum SUV to mean blood pool were calculated. Pearson's correlations between lesion size and maximum SUV were calculated.

RESULTS

The ranges of the maximum SUV were as follows: For hemangiomas (0.95-2.99), bone infarcts (0.37-3.44), bone islands (0.26-3.29), enchondromas (0.46-2.69), fibrous dysplasia (0.78-18.63), osteochondromas (1.11-2.56), Paget's disease of bone (0.93-5.65), insufficiency fractures (1.06-12.97) and for osteomyelitis (2.57-12.64). The range of the maximum SUV was lowest for osteochondromas (maximum SUV 2.56) and was highest for fibrous dysplasia (maximum SUV of 18.63). There was at least one lesion that demonstrated greater F-FDG avidity than the blood pool amongst each lesion type, with the highest maximum SUV ranging from 9.34 times blood pool mean (osteomyelitis) to 1.42 times blood pool mean (hemangiomas). There was no correlation between the maximum SUV and the lesion size except for enchondromas. Larger enchondromas had higher maximum SUV ( = 0.36, = 0.02).

CONCLUSION

The classic "do not touch" lesions and classic benign lesions can be F-FDG avid. The CT appearance of these lesions should dictate clinical management rather than the maximum SUV.

摘要

背景

在氟代脱氧葡萄糖(F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)检查中,有时会发现典型的“无需处理”的良性骨病变。这些病变常被转诊进行活检,因为解读PET/CT的医生可能不熟悉这些病变所显示的F-FDG摄取模式范围。

目的

表明“无需处理”的良性骨病变在PET/CT上的F-FDG摄取可高于血池;因此,这些病变的CT表现应决定治疗方案,而非标准化摄取值(SUV)。

方法

这项回顾性研究评估了287例独立患者,这些患者患有287个典型的“无需处理”的病变(良性囊性病变、应力性骨折、骨岛、骨梗死)或良性骨病变(血管瘤、内生软骨瘤、骨软骨瘤、骨纤维异常增殖症、佩吉特病、骨髓炎),于2006年1月1日至2018年12月1日在一家三级学术医疗机构接受了F-FDG正电子发射断层扫描/计算机断层扫描(PET/CT)检查。计算了最大SUV和平均SUV,以及最大SUV与平均血池的比值。计算了病变大小与最大SUV之间的Pearson相关性。

结果

最大SUV的范围如下:血管瘤(0.95 - 2.99)、骨梗死(0.37 - 3.44)、骨岛(0.26 - 3.29)、内生软骨瘤(0.46 - 2.69)、骨纤维异常增殖症(0.78 - 18.63)、骨软骨瘤(1.11 - 2.56)、骨佩吉特病(0.93 - 5.65)、应力性骨折(1.06 - 12.97)以及骨髓炎(2.57 - 12.64)。骨软骨瘤的最大SUV范围最低(最大SUV为2.56),骨纤维异常增殖症的最大SUV范围最高(最大SUV为18.63)。每种病变类型中至少有一个病变显示出比血池更高的F-FDG摄取,最高最大SUV范围从血池平均的9.34倍(骨髓炎)到血池平均的1.42倍(血管瘤)。除内生软骨瘤外,最大SUV与病变大小之间无相关性。较大的内生软骨瘤具有更高的最大SUV(r = 0.36,P = 0.02)。

结论

典型的“无需处理”病变和典型的良性病变可表现为F-FDG摄取。这些病变的CT表现应决定临床治疗方案,而非最大SUV。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/f94c96697d62/WJR-11-81-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/c4fe50f45800/WJR-11-81-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/accc3452edf7/WJR-11-81-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/3a52baf74db7/WJR-11-81-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/4d1a63fb01a0/WJR-11-81-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/899bb6dcdd7b/WJR-11-81-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/f94c96697d62/WJR-11-81-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/c4fe50f45800/WJR-11-81-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/accc3452edf7/WJR-11-81-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/3a52baf74db7/WJR-11-81-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/4d1a63fb01a0/WJR-11-81-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/899bb6dcdd7b/WJR-11-81-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef1e/6597458/f94c96697d62/WJR-11-81-g006.jpg

相似文献

1
Positron emission tomography/computed tomography imaging appearance of benign and classic "do not touch" osseous lesions.正电子发射断层扫描/计算机断层扫描成像显示的良性及典型“勿触碰”骨病变表现。
World J Radiol. 2019 Jun 28;11(6):81-93. doi: 10.4329/wjr.v11.i6.81.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.肾上腺肿块:18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在鉴别肾上腺肿块良恶性中的价值
Ann Nucl Med. 2009 Jun;23(4):349-54. doi: 10.1007/s12149-009-0246-4. Epub 2009 Apr 2.
4
Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.¹⁸F-FDG PET/CT 在区分癌症患者肋骨良性病变与转移中的作用。
Clin Imaging. 2014 Mar-Apr;38(2):109-14. doi: 10.1016/j.clinimag.2013.11.011. Epub 2013 Nov 27.
5
Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.18F-FDG PET/CT融合显像偶然发现的甲状腺局灶性病变:临床意义及特征的改善
J Nucl Med. 2006 Apr;47(4):609-15.
6
Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.肺肿瘤患者中,(18)F-FDG PET/CT上最大标准化摄取值和平均标准化摄取值测量以及诊断性CT上肿瘤大小测量的观察者间变异性。
Acta Radiol. 2010 Sep;51(7):782-8. doi: 10.3109/02841851.2010.497772.
7
Dual time point 2-[18F]fluoro-2'-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis.双时间点2-[18F]氟-2'-脱氧葡萄糖正电子发射断层扫描在慢性细菌性骨髓炎中的应用
Nucl Med Commun. 2004 Aug;25(8):819-23. doi: 10.1097/01.mnm.0000135600.23896.9d.
8
The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.(18)F-FDG-PET/CT在良性和恶性肌肉骨骼肿瘤中的临床疗效。
Ann Nucl Med. 2008 Aug;22(7):603-9. doi: 10.1007/s12149-008-0151-2. Epub 2008 Aug 29.
9
Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?双时间点氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在癌症患者恶性与良性病变鉴别中的应用。它总能奏效吗?
Indian J Nucl Med. 2015 Oct-Dec;30(4):314-9. doi: 10.4103/0972-3919.159693.
10
Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease.18F-FDG PET/CT在乳腺外佩吉特病诊断及分期中的应用价值。
Nucl Med Commun. 2015 Sep;36(9):892-7. doi: 10.1097/MNM.0000000000000340.

引用本文的文献

1
Cross-sectional evaluation of FGD-avid polyostotic fibrous dysplasia: MRI, CT and PET/MRI findings.FDG摄取阳性的多骨型纤维结构不良的横断面评估:MRI、CT及PET/MRI表现
Eur J Hybrid Imaging. 2022 Oct 3;6(1):19. doi: 10.1186/s41824-022-00139-0.
2
Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!佩吉特病在肿瘤学中使用不同放射性药物的PET检查中是常见陷阱:并非所有闪光的都是金子!
J Clin Med. 2022 Sep 13;11(18):5372. doi: 10.3390/jcm11185372.
3
Multidisciplinary management of spinal metastases: what the radiologist needs to know.

本文引用的文献

1
Fibrous dysplasia for radiologists: beyond ground glass bone matrix.放射科医生眼中的骨纤维异常增殖症:超越磨玻璃样骨基质
Insights Imaging. 2018 Dec;9(6):1035-1056. doi: 10.1007/s13244-018-0666-6. Epub 2018 Nov 27.
2
A Rare Case of an Osteolytic Bone-infarct-associated Osteosarcoma: Case Report with Radiographic and Histopathologic Correlation, and Literature Review.溶骨性骨梗死相关骨肉瘤1例罕见病例:影像学与组织病理学对照病例报告及文献复习
Cureus. 2018 Jun 11;10(6):e2777. doi: 10.7759/cureus.2777.
3
Accuracy of Opposed-phase Magnetic Resonance Imaging for the Evaluation of Treated and Untreated Spinal Metastases.
脊柱转移瘤的多学科管理:放射科医生需要了解什么。
Br J Radiol. 2022 Sep 1;95(1138):20220266. doi: 10.1259/bjr.20220266. Epub 2022 Aug 10.
4
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing F-FDG PET/CT-derived parameters.利用 F-FDG PET/CT 衍生参数区分软组织和骨肉瘤与良性病变。
BMC Med Imaging. 2020 Jul 25;20(1):85. doi: 10.1186/s12880-020-00486-z.
对比相磁共振成像评估治疗和未治疗脊柱转移瘤的准确性。
Acad Radiol. 2018 Jul;25(7):877-882. doi: 10.1016/j.acra.2017.11.022. Epub 2018 Feb 3.
4
Accuracy of CT Attenuation Measurement for Differentiating Treated Osteoblastic Metastases From Enostoses.CT 衰减测量鉴别治疗性成骨转移与骨样骨瘤的准确性。
AJR Am J Roentgenol. 2018 Mar;210(3):615-620. doi: 10.2214/AJR.17.18638. Epub 2018 Jan 11.
5
Concordance between fine-needle aspiration and core biopsies for osseous lesions by lesion imaging appearance and CT attenuation.根据病变影像学表现和 CT 衰减值,比较细针抽吸和核心活检在骨病变中的一致性。
Radiol Med. 2018 Apr;123(4):254-259. doi: 10.1007/s11547-017-0841-8. Epub 2017 Dec 16.
6
Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT.基于证据的正电子发射断层扫描-计算机断层扫描(PET-CT)上氟脱氧葡萄糖偶然局灶性摄取的管理
Br J Radiol. 2018 Apr;91(1084):20170774. doi: 10.1259/bjr.20170774. Epub 2018 Jan 31.
7
Subspecialization in radiology - Is it time to hatch out of the cocoon?放射学的亚专业——是时候破茧而出了吗?
Indian J Radiol Imaging. 2017 Jul-Sep;27(3):261-262. doi: 10.4103/ijri.IJRI_345_17.
8
F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature.F-18 FDG PET对软骨样肿瘤良恶性的鉴别:文献系统综述
Skeletal Radiol. 2017 Sep;46(9):1233-1239. doi: 10.1007/s00256-017-2685-7. Epub 2017 Jun 12.
9
Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.良性骨病变可能摄取 FDG 并模拟恶性肿瘤。
Semin Nucl Med. 2017 Jul;47(4):322-351. doi: 10.1053/j.semnuclmed.2017.02.004. Epub 2017 Apr 12.
10
Malignant transformation in monostotic fibrous dysplasia: clinical features, imaging features, outcomes in 10 patients, and review.单骨型骨纤维异常增殖症的恶性转化:10例患者的临床特征、影像特征、治疗结果及文献复习
Medicine (Baltimore). 2015 Jan;94(3):e369. doi: 10.1097/MD.0000000000000369.